Blog

March 18, 2020

Our Commitment to Cancer Care During COVID-19

Healthcare systems and providers around the world are coming together and adapting quickly to deliver care to patients under extraordinary circumstances as the coronavirus pandemic evolves.

Press

January 17, 2020

Contextual Genomics and EORLA Partner for Early Access to ctDNA Cancer Testing

Contextual Genomics and Eastern Ontario Regional Laboratory Association, a nonprofit organization offering high quality, patient focused, hospital-based lab services in Eastern Ontario, announced that they have partnered to bring Contextual Genomics’ ctDNA cancer genomic testing to EORLA’s Champlain Local Health Integration Network of Eastern Ontario, Canada.

Press

January 13, 2020

Contextual Genomics and Lab Genomics Partner for Liquid Biopsy Cancer Testing

Contextual Genomics and Lab Genomics, a personalized medicine company providing state of the art molecular genetic testing in Southern California, announced that they have signed an agreement enabling Lab Genomics to offer Contextual Genomics’ quality assured Next Generation Sequencing based ctDNA cancer genomic testing to patients in Southern California and other parts of the United States.

Press

January 10, 2020

Brady Davis Joins Contextual Genomics’ Executive Team

Contextual Genomics announced that it has named Brady Davis to its executive team. Mr. Davis, a veteran of the life sciences, healthcare and software industries, joins as Senior Vice President, Business Development of the Company, responsible for global strategy and business development.

More Information at Your Fingertips

Every Canexia Health report comes with therapeutic recommendations based on specific gene mutations and patient profiles, with clinical trials reviewed and selected by certified clinical molecular geneticists.

Learn More